why choose us

First received: August 05, 2022

Clinical Trial: Imatinib TDM in GIST

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Gastrointestinal Stromal Tumors

Study Type: INTERVENTIONAL


Official Title: A Phase 2 Study of Imatinib Therapeutic Drug Monitoring in Gastrointestinal Stromal Tumor

Brief Summary: Imatinib can lead to long recurrence free survival in patients diagnosed with gastrointestinal stromal tumors (GIST); however side effects can significantly hinder quality of life for our patients.This study will use therapeutic drug monitoring to improve quality of life and symptoms and assess how many patients maintain therapeutic levels.Free drug levels and pharmokinetics of imatinib will also be monitored.

Read more